3 Year Absolute Returns
84.88% ↑
NAV (₹) on 18 Dec 2025
42.39
1 Day NAV Change
-0.24%
Risk Level
Very High Risk
Rating
-
Mirae Asset Healthcare Fund - Direct Plan is a Equity mutual fund categorized under Sector, offered by Mirae Asset Global Investments (India) Pvt. Ltd.. Launched on 11 Jun 2018, investors can start ... Read more
AUM
₹ 2,812.12 Cr
| Sectors | Weightage |
|---|---|
| Pharmaceuticals | 79.55% |
| Hospitals & Medical Services | 15.37% |
| Medical Research Services | 1.75% |
| Treps/Reverse Repo | 0.77% |
| IT Enabled Services | 0.77% |
| Chemicals - Inorganic - Others | 0.71% |
| Chemicals - Speciality | 0.64% |
| Medical Equipment & Accessories | 0.58% |
| Mutual Fund Units | 0.01% |
| Name | Weightage | Value (in Cr.) | Sector |
|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | 11.41% | ₹ 306.90 | Pharmaceuticals |
| Divi's Laboratories Ltd. | 7.65% | ₹ 205.82 | Pharmaceuticals |
| Aurobindo Pharma Ltd. | 6.98% | ₹ 187.79 | Pharmaceuticals |
| Cipla Ltd. | 6.23% | ₹ 167.54 | Pharmaceuticals |
| Apollo Hospitals Enterprise Ltd. | 5.76% | ₹ 154.84 | Hospitals & Medical Services |
| Glenmark Pharmaceuticals Ltd. | 5.49% | ₹ 147.68 | Pharmaceuticals |
| Lupin Ltd. | 5.41% | ₹ 145.69 | Pharmaceuticals |
| Dr. Reddy's Laboratories Ltd. | 4.50% | ₹ 121.05 | Pharmaceuticals |
| Krishna Institute of Medical Sciences Ltd. | 4.15% | ₹ 111.58 | Hospitals & Medical Services |
| Cohance Lifesciences Ltd. | 3.88% | ₹ 104.34 | Pharmaceuticals |
| Aster DM Healthcare Ltd. | 3.01% | ₹ 81.02 | Hospitals & Medical Services |
| Torrent Pharmaceuticals Ltd. | 2.91% | ₹ 78.32 | Pharmaceuticals |
| Wockhardt Ltd. | 2.81% | ₹ 75.69 | Pharmaceuticals |
| Gland Pharma Ltd. | 2.80% | ₹ 75.31 | Pharmaceuticals |
| JB Chemicals & Pharmaceuticals Ltd. | 2.80% | ₹ 75.24 | Pharmaceuticals |
| Onesource Specialty Pharma Ltd. | 2.64% | ₹ 71.03 | Pharmaceuticals |
| IPCA Laboratories Ltd. | 2.57% | ₹ 69.14 | Pharmaceuticals |
| Mankind Pharma Ltd. | 2.49% | ₹ 67.10 | Pharmaceuticals |
| Sai Life Sciences Ltd. | 2.48% | ₹ 66.72 | Pharmaceuticals |
| Alkem Laboratories Ltd. | 2.46% | ₹ 66.23 | Pharmaceuticals |
| Fortis Healthcare Ltd. | 2.45% | ₹ 65.90 | Hospitals & Medical Services |
| Syngene International Ltd. | 1.75% | ₹ 47.02 | Medical Research Services |
| Eris Lifesciences Ltd. | 1.66% | ₹ 44.68 | Pharmaceuticals |
| Biocon Ltd. | 1.20% | ₹ 32.37 | Pharmaceuticals |
| Alembic Pharmaceuticals Ltd. | 1.10% | ₹ 29.46 | Pharmaceuticals |
| Sagility India Ltd. | 0.77% | ₹ 20.79 | IT Enabled Services |
| TREPS | 0.77% | ₹ 20.68 | Others |
| Deepak Nitrite Ltd. | 0.71% | ₹ 19.09 | Chemicals - Inorganic - Others |
| Neogen Chemicals Ltd. | 0.64% | ₹ 17.30 | Chemicals - Speciality |
| Laxmi Dental Ltd. | 0.58% | ₹ 15.62 | Medical Equipment & Accessories |
| Zydus Lifesciences Ltd. | 0.08% | ₹ 2.02 | Pharmaceuticals |
| Mirae Asset Liquid Fund-Direct Plan-Growth | 0.01% | ₹ 0.23 | Others |
| Annualised returns | ||||
|---|---|---|---|---|
| 9M | 1Y | 2Y | 3Y | |
| Fund returns | 7.83% | 0.28% | 19.03% | 22.73% |
| Category returns | 12.61% | 0.69% | 15.54% | 26.16% |
The investment objective of the scheme is to seek to generate long term capital appreciation through investing in equity and equity related securities of companies benefitting directly or indirectly ... Read more
|
Scheme Name
|
NAV
|
Returns
1Y
3Y
5Y
|
AUM (Cr)
|
Expense Ratio
|
Risk Meter
|
||
|---|---|---|---|---|---|---|---|
|
Mirae Asset Large Cap Fund
Diversified
Regular
|
₹32.35 | 5.98% | 32.27% | 62.30% | ₹41,864 | 1.51% |
Very High
|
|
Mirae Asset Large Cap Fund
Diversified
Regular
|
₹32.35 | 5.98% | 32.27% | 62.30% | ₹41,864 | 1.51% |
Very High
|
|
Mirae Asset Midcap Fund
Diversified
Regular
|
₹26.56 | -3.60% | 32.24% | 91.93% | ₹18,380 | 1.65% |
Very High
|
|
Mirae Asset Midcap Fund
Diversified
Regular
|
₹26.56 | -3.60% | 32.24% | 91.93% | ₹18,380 | 1.65% |
Very High
|
|
Mirae Asset Focused Fund - Direct Plan
MidsmallCap
Direct
|
₹25.75 | -0.48% | 28.85% | 79.16% | ₹7,904 | 0.57% |
Very High
|
|
Mirae Asset Focused Fund - Direct Plan
MidsmallCap
Direct
|
₹25.75 | -0.48% | 28.85% | 79.16% | ₹7,904 | 0.57% |
Very High
|
|
Mirae Asset Great Consumer Fund - Direct Plan
Diversified
Direct
|
₹67.42 | -5.23% | 28.04% | 63.71% | ₹4,787 | 0.41% |
Very High
|
|
Mirae Asset Great Consumer Fund - Direct Plan
Diversified
Direct
|
₹67.42 | -5.23% | 28.04% | 63.71% | ₹4,787 | 0.41% |
Very High
|
|
Mirae Asset CRISIL IBX Gilt Index - April 2033 Index Fund-DP
Gilt
Direct
|
₹13.05 | 7.68% | 27.26% | 0.00% | ₹229 | 0.11% |
Moderate
|
|
Mirae Asset CRISIL IBX Gilt Index - April 2033 Index Fund-DP
Gilt
Direct
|
₹13.05 | 7.68% | 27.23% | 0.00% | ₹229 | 0.11% |
Moderate
|
What is the current NAV of Mirae Asset Healthcare Fund - Direct Plan Growth?
The current Net Asset Value (NAV) of Mirae Asset Healthcare Fund - Direct Plan Growth is ₹42.39 as of 18 Dec 2025. NAV represents the per-unit market value of the fund and is updated daily based on the closing prices of the underlying securities.
What is the fund size (AUM) of Mirae Asset Healthcare Fund - Direct Plan Growth?
The Assets Under Management (AUM) of Mirae Asset Healthcare Fund - Direct Plan Growth is ₹2,812.12 Crores. AUM indicates the total market value of assets managed by the fund and reflects investor confidence and fund popularity.
What are the historical returns of Mirae Asset Healthcare Fund - Direct Plan Growth?
Mirae Asset Healthcare Fund - Direct Plan Growth has delivered returns of 0.28% (1 Year), 22.73% (3 Year), 16.85% (5 Year). Past performance does not guarantee future results, and investors should consider their risk appetite before investing.
What is the risk level of Mirae Asset Healthcare Fund - Direct Plan Growth?
Mirae Asset Healthcare Fund - Direct Plan Growth has a risk rating of 'Very High' as per the SEBI Riskometer. This indicates the fund is suitable for very aggressive investors comfortable with significant market volatility. Investors should align their investment choices with their personal risk tolerance and financial goals.
What is the minimum investment amount for Mirae Asset Healthcare Fund - Direct Plan Growth?
The minimum lumpsum investment required for Mirae Asset Healthcare Fund - Direct Plan Growth is ₹5,000. The fund also offers SIP (Systematic Investment Plan) option starting from as low as ₹99, making it accessible for regular investments. This allows investors to start their mutual fund journey with a manageable amount.
Disclaimer: This is 3rd Party content/feed, viewers are requested to use their discretion and conduct proper diligence before investing, GoodReturns does not take any liability on the genuineness and correctness of the information in this article